Physician profile
John P Gavin
NPI 1023211745
$477.56
in general payments reported to CMS, 2019-2025
12 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Pediatric Otolaryngology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $34.44 · 2021: $19.82 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $146.01 | 2019-2025 | Halo |
| Jazz Pharmaceuticals INC. | $60.86 | 2019 | |
| Alk-Abello, INC | $53.77 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $53.47 | 2019 | |
| Medtronic USA, INC. | $41.75 | 2019 | |
| Acclarent, INC | $25.34 | 2019 | |
| Shire North American Group INC | $17.05 | 2019 | |
| Intersect Ent, INC. | $17.02 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.55 | 2020 | |
| Glaxosmithkline, LLC. | $16.24 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.04 | 2019 | |
| Grifols USA, LLC | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gavin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.